Jul 16, 2021
This podcast, supported by an educational grant from Eli Lilly, explores the latest developments in RET‑driven lung cancer that were presented at the American Society of Clinical Oncology’s (ASCO) 2021 virtual conference. Hear from two experts, Dr Maximilian Hochmair and Dr Fernando Lopez-Rios, as they discuss the importance of the RET gene, the latest safety and efficacy information, the role of testing, and future predictions within this landscape.